PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 114 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 45.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $323,000 | 0.0% | 125,770 | -2.6% | 0.00% | 0.0% |
| Q4 2020 | $323,000 | +20.5% | 129,180 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $268,000 | -31.6% | 129,290 | +2.3% | 0.00% | -50.0% |
| Q2 2020 | $392,000 | +180.0% | 126,438 | +105.8% | 0.00% | +100.0% |
| Q1 2020 | $140,000 | -39.7% | 61,424 | +24.2% | 0.00% | 0.0% |
| Q2 2019 | $232,000 | +39.8% | 49,440 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $166,000 | +25.8% | 49,440 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $132,000 | -73.1% | 49,440 | -43.7% | 0.00% | -66.7% |
| Q3 2018 | $491,000 | -4.3% | 87,740 | -13.2% | 0.00% | 0.0% |
| Q2 2018 | $513,000 | – | 101,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |